Table 1 Demographic and clinical characteristics of NVAF patients according to anticoagulation status
Characteristics | Controlled patients | Uncontrolled patients | Total (N = 501) | ||
|---|---|---|---|---|---|
NOACs (N = 261) | VKA (N = 69) | Total (N = 330) | VKA (N = 171) | ||
Age (years, mean ± SD) | 79.4 (8.6) | 78.7 (9.4) | 79.3 (8.8) | 80.4 (8.7) | 79.7 (8.7) |
Gender | |||||
Female (n, %) | 119 (45.6) | 33 (47.8) | 152 (46.1) | 95 (55.6) | 247 (49.3) |
Race (n, %) | |||||
Caucasian | 261 (100.0) | 69 (100.0) | 330 (100.0) | 171 (100.0) | 501 (100.0) |
Age at diagnosis (years, mean ± SD) | 74.9 (9.1) | 75.8 (9.6) | 75.0 (9.2) | 77.3 (8.7) | 75.8 (9.1) |
Type of AF (n, %) | |||||
Paroxysmal | 84 (32.2) | 18 (26.1) | 102 (30.9) | 51 (29.8) | 153 (30.5) |
Persisting | 22 (8.4) | 11 (15.9) | 33 (10.0) | 23 (13.5) | 56 (11.2) |
Permanent | 155 (59.4) | 40 (58.0) | 195 (59.1) | 56.1 (291) | 291 (58.1) |